Cancer Vaccines, Treatment of the Future: With Emphasis on HER2-Positive Breast Cancer
Breast cancer is one of the leading causes of death in women. With improvements in early-stage diagnosis and targeted therapies, there has been an improvement in the overall survival rate in breast cancer over the past decade. Despite the development of targeted therapies, tyrosine kinase inhibitors...
Main Authors: | Sandeep Pallerla, Ata ur Rahman Mohammed Abdul, Jill Comeau, Seetharama Jois |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/2/779 |
Similar Items
-
Virus-like particle display of HER2 induces potent anti-cancer responses
by: Arianna Palladini, et al.
Published: (2018-03-01) -
Cancer Vaccines: Promising Therapeutics or an Unattainable Dream
by: Howard Donninger, et al.
Published: (2021-06-01) -
Cancer Vaccines Co-Targeting HER2/Neu and IGF1R
by: Carla De Giovanni, et al.
Published: (2019-04-01) -
A brief report of toxicity end points of HER2 vaccines for the treatment of patients with HER2+ breast cancer
by: Costa R, et al.
Published: (2019-01-01) -
Nanoparticles to Improve the Efficacy of Peptide-Based Cancer Vaccines
by: Anna Lucia Tornesello, et al.
Published: (2020-04-01)